Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Silver

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Health Services Manager|June 11, 1979
Spotlight on...disciplineD F Silver
Health Services Manager|March 13, 1978
Streamline your paid-days leave programsD F Silver
Hospitals|August 1, 1978
Counseling and peer review are key disciplinary proceduresD F Silver
Gynecologic Oncology|May 18, 1999
Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effectD F Silver, M S Piver
American Journal of Clinical Oncology|October 16, 1999
Gemcitabine salvage chemotherapy for patients with gynecologic malignancies of the ovary, fallopian tube, and peritoneumD F Silver, M S Piver
Gynecologic Oncology|August 25, 2001
Choices in creating continent urostomies following pelvic exenteration for gynecologic malignanciesD F Silver, T R Ashwell
Gynecologic Oncology|May 2, 2001
A vaginal and extraperitoneal approach to surgically stage patients with endometrial cancerD F Silver, C R Wheeless, F M Abbas
Journal of the Society for Gynecologic Investigation|November 14, 1997
The effect of recombinant growth hormone on the strength of ileal anastomoses in a rat modelD F Silver, C R Wheeless, N H Dubin
The Journal of Surgical Research|June 29, 1999
Recombinant growth hormone's effects on the strength and thickness of radiation-injured ileal anastomoses: a rat modelD F Silver, A Simon, N H Dubin, et al.
Gynecologic Oncology|February 18, 1999
Effects of IL-12 on human ovarian tumors engrafted into SCID miceD F Silver, R E Hempling, M S Piver, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Health Services Manager|June 11, 1979
Spotlight on...disciplineD F Silver
Health Services Manager|March 13, 1978
Streamline your paid-days leave programsD F Silver
Hospitals|August 1, 1978
Counseling and peer review are key disciplinary proceduresD F Silver
Gynecologic Oncology|May 18, 1999
Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effectD F Silver, M S Piver
American Journal of Clinical Oncology|October 16, 1999
Gemcitabine salvage chemotherapy for patients with gynecologic malignancies of the ovary, fallopian tube, and peritoneumD F Silver, M S Piver
Gynecologic Oncology|August 25, 2001
Choices in creating continent urostomies following pelvic exenteration for gynecologic malignanciesD F Silver, T R Ashwell
Gynecologic Oncology|May 2, 2001
A vaginal and extraperitoneal approach to surgically stage patients with endometrial cancerD F Silver, C R Wheeless, F M Abbas
Journal of the Society for Gynecologic Investigation|November 14, 1997
The effect of recombinant growth hormone on the strength of ileal anastomoses in a rat modelD F Silver, C R Wheeless, N H Dubin
The Journal of Surgical Research|June 29, 1999
Recombinant growth hormone's effects on the strength and thickness of radiation-injured ileal anastomoses: a rat modelD F Silver, A Simon, N H Dubin, et al.
Gynecologic Oncology|February 18, 1999
Effects of IL-12 on human ovarian tumors engrafted into SCID miceD F Silver, R E Hempling, M S Piver, et al.
Pageof 2